Alphine Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 24-12-2024
- Paid Up Capital ₹ 0.11 M
as on 24-12-2024
- Company Age 10 Year, 4 Months
- Open Charges ₹ 1.87 Cr
as on 24-12-2024
About Alphine Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹1.87 Cr.
Bhaskara Bejjenki and Swathi Medoju serve as directors at the Company.
- CIN/LLPIN
U33120TG2014PTC095228
- Company No.
095228
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2014
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Alphine Pharmaceuticals Private Limited offer?
Alphine Pharmaceuticals Private Limited offers a wide range of products and services, including Antihistamines, Chlorpheniramine Maleate Tablets, Nutraceuticals & Dietary Supplements, Mineral Supplement, Anti Asthma Drug, Salbutamol Sulphate Tablet, Diabetes Medicine, Metformin Tablets, Anti Infective Drugs & Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Alphine Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhaskara Bejjenki  | Managing Director | 11-Aug-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swathi Medoju | Director | 11-Aug-2014 | Current |
Financial Performance of Alphine Pharmaceuticals.
Enhance accessibility to Alphine Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Alphine Pharmaceuticals?
Unlock access to Alphine Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Andhra Bank Creation Date: 19 Mar 2015 | ₹1.87 Cr | Open |
How Many Employees Work at Alphine Pharmaceuticals?
Unlock and access historical data on people associated with Alphine Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alphine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alphine Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
